Fabian StiefelAssociate Director in Cell Culture Bioprocess Development at Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Fabian holds a diploma degree in biotechnology and a master of science in pharmaceutical therapy. During his Ph.D. at the University of Ulm, he focused on the genetic regulation of CHO cell during the bioprocess. Since then, he worked as a Postdoc and Senior Scientist in various positions concerning the development of bioprocess with major focus on cell culture media and targeted modulation of product quality. Currently he is working as Associate Director in the Bioprocess Development Department at Boehringer Ingelheim, where he is responsible for late stage process development.